Dataset Information


Computed tomography findings after radiofrequency ablation in locally advanced pancreatic cancer.

ABSTRACT: The purpose of the study was to provide a systematic evaluation of the computed tomography(CT) findings after radiofrequency ablation (RFA) in locally advanced pancreatic cancer(LAPC).Eighteen patients with intra-operative RFA-treated LAPC were included in a prospective case series. All CT-scans performed prior to RFA and 1 week and 3 months of post-RFA, according to standard regimen, were assessed by two radiologists in consensus, using standardized radiological scoring lists.51 CT-scans were assessed. One week after RFA, the ablation zone was visible in all patients as a (partially) sharply defined (83%), heterogeneous area (94%). At 3 months of follow-up, the ablation zone was completely invaded by tumor in 67% of patients and still present, but decreased in 33%. In two patients (11%), local thrombosis and/or occlusion of the superior mesenteric vein occurred. The occlusions persisted without clinical consequences and the thrombosis disappeared. A peripancreatic fluid collection was visible 1 week after RFA in 3 patients, wherein the ablation zone extended ventrally outside of the pancreas.Directly after RFA for LAPC, a well-defined ablation zone is visible on CT-imaging. This ablation zone is usually replaced by tumor ingrowth after 3 months. Moreover, the ablation zone regularly included vascular structures, with rare asymptomatic venous occlusion or thrombosis and without adverse effects on arteries.


PROVIDER: S-EPMC6132871 | BioStudies | 2018-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2012-01-01 | S-EPMC3393883 | BioStudies
1000-01-01 | S-EPMC5406608 | BioStudies
2007-01-01 | S-EPMC2225513 | BioStudies
2020-01-01 | S-EPMC7491221 | BioStudies
2020-01-01 | S-EPMC7521687 | BioStudies
2015-01-01 | S-EPMC4328454 | BioStudies
2017-01-01 | S-EPMC5409808 | BioStudies
2017-01-01 | S-EPMC5221821 | BioStudies
2016-01-01 | S-EPMC6095431 | BioStudies
2020-01-01 | S-EPMC7507426 | BioStudies